134 related articles for article (PubMed ID: 3088700)
1. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
[TBL] [Abstract][Full Text] [Related]
2. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
Munsat TL; Taft J; Kasdon D
Neurol Clin; 1987 Feb; 5(1):159-70. PubMed ID: 3104751
[TBL] [Abstract][Full Text] [Related]
4. Intravenous thyrotropin-releasing hormone in patients with amyotrophic lateral sclerosis. Dose-response and randomized concurrent placebo-controlled pilot studies.
Brooks BR; Sufit RL; Montgomery GK; Beaulieu DA; Erickson LM
Neurol Clin; 1987 Feb; 5(1):143-58. PubMed ID: 3104750
[TBL] [Abstract][Full Text] [Related]
5. [Spinal mechanism of the antispastic action of TRH in patients with amyotrophic lateral sclerosis].
Morin C; Pierrot-Deseilligny E
Rev Neurol (Paris); 1988; 144(11):701-3. PubMed ID: 3148185
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary clinical study on the treatment of amyotrophic lateral sclerosis with TRH].
Formisano R; Antonini G; Bove R; Millefiorini M; Ruggieri S
Clin Ter; 1986 Dec; 119(6):479-81. PubMed ID: 3102155
[No Abstract] [Full Text] [Related]
7. [Treatment of amyotrophic lateral sclerosis with TRH].
Klimek A; Szulc-Kuberska J; Czernielewska-Rutkowska I; Głuszcz-Zielińska A
Neurol Neurochir Pol; 1988; 22(3):206-10. PubMed ID: 3146705
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of amyotrophic lateral sclerosis with daily intrathecal TRH. A year's experience. Pilot study II].
Patrignani J; Proaño J; Morales MD
Neurologia; 1992 Jan; 7(1):4-9. PubMed ID: 1596403
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.
Mitsumoto H; Salgado ED; Negroski D; Hanson MR; Salanga VD; Wilber JF; Wilbourn AJ; Breuer AC; Leatherman J
Neurology; 1986 Feb; 36(2):152-9. PubMed ID: 3080695
[TBL] [Abstract][Full Text] [Related]
10. TRH-induced reflex changes in patients with ALS.
Hawley RJ; Sirdofsky M; Kratz R
Electromyogr Clin Neurophysiol; 1989; 29(7-8):465-7. PubMed ID: 2514091
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.
Caroscio JT; Cohen JA; Zawodniak J; Takai V; Shapiro A; Blaustein S; Mulvihill MN; Loucas SP; Gudesblatt M; Rube D
Neurology; 1986 Feb; 36(2):141-5. PubMed ID: 3080693
[TBL] [Abstract][Full Text] [Related]
12. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
[TBL] [Abstract][Full Text] [Related]
13. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.
Engel WK; Siddique T; Nicoloff JT
Lancet; 1983 Jul; 2(8341):73-5. PubMed ID: 6134961
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
Thielen T; Stober T; Schimrigk K
Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
[No Abstract] [Full Text] [Related]
15. Intrathecal thyrotropin-releasing hormone therapy of amyotrophic lateral sclerosis.
Stober T; Schimrigk K; Dietzsch S; Thielen T
J Neurol; 1985; 232(1):13-4. PubMed ID: 3923160
[TBL] [Abstract][Full Text] [Related]
16. Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis. Committee on Health Care Issues, American Neurological Association.
Ann Neurol; 1987 Oct; 22(4):541-3. PubMed ID: 3124710
[No Abstract] [Full Text] [Related]
17. [Note on the use of TRH in amyotrophic lateral sclerosis].
Serratrice G
Bull Acad Natl Med; 1985 Oct; 169(7):1013-7. PubMed ID: 3938669
[No Abstract] [Full Text] [Related]
18. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
19. [Trials of 1-cysteine, TRH and 5HTP in amyotrophic lateral sclerosis].
Akiguchi I; Kato T; Sugiyama H
Rinsho Shinkeigaku; 1984 Dec; 24(12):1270-3. PubMed ID: 6442975
[No Abstract] [Full Text] [Related]
20. Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy.
Kato Z; Okuda M; Okumura Y; Arai T; Teramoto T; Nishimura M; Kaneko H; Kondo N
J Child Neurol; 2009 Aug; 24(8):1010-2. PubMed ID: 19666885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
